[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @stock_logging Stock.Logging Stock.Logging posts on X about $camx, $camxst, $krys, eps the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1935417778166439936/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +303% ### Mentions: XX [#](/creator/twitter::1935417778166439936/posts_active)  - X Week XX -XX% - X Month XX +231% ### Followers: XXX [#](/creator/twitter::1935417778166439936/followers)  - X Week XXX +7.70% - X Month XXX +358% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1935417778166439936/influencer_rank)  ### Social Influence [#](/creator/twitter::1935417778166439936/influence) --- **Social category influence** [currencies](/list/currencies) XXX% [countries](/list/countries) XXXX% [travel destinations](/list/travel-destinations) XXXX% [stocks](/list/stocks) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% [finance](/list/finance) XXXX% **Social topic influence** [$camx](/topic/$camx) 8.7%, [$camxst](/topic/$camxst) 8.7%, [$krys](/topic/$krys) 8.7%, [eps](/topic/eps) 4.35%, [sek](/topic/sek) 4.35%, [india](/topic/india) 4.35%, [japan](/topic/japan) 4.35%, [currency](/topic/currency) 4.35%, [stockholm](/topic/stockholm) 4.35%, [aesthetics](/topic/aesthetics) XXXX% **Top accounts mentioned or mentioned by** [@marcalcarbo](/creator/undefined) [@oddhootcapital](/creator/undefined) [@realyuvaraj](/creator/undefined) [@themapreducer](/creator/undefined) [@exclamotite69](/creator/undefined) [@sycapital](/creator/undefined) [@topsecretstocks](/creator/undefined) [@szewinvest](/creator/undefined) [@joinyellowbrick](/creator/undefined) [@mufasa_capital](/creator/undefined) [@sy_capital](/creator/undefined) **Top assets mentioned** [Krystal Biotech, Inc. Common Stock (KRYS)](/topic/$krys) [NuCypher (NU)](/topic/$nu) [MercadoLibre Inc (MELI)](/topic/$meli) [Interlay (INTR)](/topic/$intr) [AST SpaceMobile, Inc. Class A Common Stock (ASTS)](/topic/$asts) [Sezzle Inc. Common Stock (SEZL)](/topic/$sezl) [Pagaya Technologies Ltd. Class A Ordinary Shares (PGY)](/topic/$pgy) [Upstart Holdings, Inc. Common stock (UPST)](/topic/$upst) [Hundred Million (100M)](/topic/$100m) ### Top Social Posts [#](/creator/twitter::1935417778166439936/posts) --- Top posts by engagements in the last XX hours "$CAMX.ST $CAMX Strong quarterly results from Camurus (part of my biotech basket): ➡ Revenue: SEK 675.5m +51.8% YoY (vs. SEK 653m est.) ➡ Operating profit: SEK 292.05m (43.2% margin) +253.5% YoY ➡ EPS: SEK XXXX +226.4% YoY (vs. SEK XXXX est.) Unchallenged market leader in opioid addiction treatment strong pipeline resubmission for CAM2029 (acromegaly treatment) in the U.S. expected in Q3/25 a recently announced long-term collaboration with Eli Lilly ($LLY) on its proprietary FluidCrystal technology incredible operating leverage lots to like here. In my view one of the best high-growth stocks"  [@stock_logging](/creator/x/stock_logging) on [X](/post/tweet/1945770553790411061) 2025-07-17 09:00:25 UTC XXX followers, 1210 engagements "@MarcalCarbo Absolutely Great thing about X is that so many people share their high-quality research for free really helps clear up misconceptions like this"  [@stock_logging](/creator/x/stock_logging) on [X](/post/tweet/1946203852933357573) 2025-07-18 13:42:11 UTC XXX followers, XX engagements "The company operates X segments: Ad Platform: Programmatic advertising platform in Japan with an SSP (publishers / websites monetize ad inventory) a DSP (advertisers/agencies buy ad slots) plus add-on services like publisher support. Cash cow growing 1015% p.a. Overseas Business: Programmatic advertising outside Japan (SEA India U.S.) acquired in 2023 now consolidated under Ad Platform. Digital PR: Acquired in 2024 connects influencers and content creators with brands for marketing campaigns. Marketing SaaS the crown jewel: XX% revenue CAGR since 2021 rising ARPU XXX% churn/quarter. Already"  [@stock_logging](/creator/x/stock_logging) on [X](/post/tweet/1945462278503215373) 2025-07-16 12:35:26 UTC XXX followers, XXX engagements "@sy_capital Yes indeed was down almost XX% this morning in Stockholm (I'm on vacation today so lots of time to check stock tickers 😂). Price has recovered meanwhile. Agreed really good numbers. And that despite a currency headwind of XX % 🤯"  [@stock_logging](/creator/x/stock_logging) on [X](/post/tweet/1945788407633887334) 2025-07-17 10:11:22 UTC XXX followers, XX engagements "$KRYS Strong study results for Krystal Biotech and its subsidiary Jeune Aesthetics In a randomized double-blind and placebo-controlled Phase X study pipeline candidate KB301 showed significant improvements in severe wrinkles in the dcollet area over XX months as assessed by both investigators (left column) and patients themselves (right column). Important: There is currently no FDA-approved injectable treatment for the dcollet area. Investing in $KRYS therefore not only gives exposure to the market leader in the treatment of dystrophic epidermolysis bullosa (DEB) a rare skin disease but also"  [@stock_logging](/creator/x/stock_logging) on [X](/post/tweet/1948385568758370719) 2025-07-24 14:11:33 UTC XXX followers, XXX engagements "$CRMD Ive already increased my Cormedix position by XX% this month and Im considering adding more as the valuation keeps getting cheaper. Below is a simple projection I put together. Feedback appreciated Business model in one sentence (for those unfamiliar with the stock): CorMedix sells DefenCath a catheter lock solution that prevents infections in dialysis patients. Additional indications include TPN (Total Parenteral Nutrition) and oncology. Dialysis: TAM: 37m vials (inpatient) + 3.8m vials (outpatient) = 40.8m vials total (source: company presentation). Price per vial: currently $XXX but"  [@stock_logging](/creator/x/stock_logging) on [X](/post/tweet/1946561791632253289) 2025-07-19 13:24:31 UTC XXX followers, 4855 engagements "Portfolio Update June 2025 📊 Performance YTD (measured as TTWROR in EUR): XXXXX % (converted to USD it would be about XX% higher) ➡ Holdings: $INT.ST $INT $SLYG.DE $SLYG $NXSN.TA $NXSN $NU $MELI $7378.T $INTR $ALSTI $ALSTI.PA $247A.T $KURN.SW $KURN $ASTS $5621.T $SOFW.TA $SOFW $4374.T $5134.T $HROW $CAMX.ST $CAMX $4377.T $KRYS $4493.T $277A.T $215A.T $CRMD $4475.T $9911.HK $ALLIX $ALLIX.PA $4419.T $ETON ➕ New positions $CAMX.ST $KURN.SW $215A.T $CRMD $WALLIX.PA $9911.HK 🔼 Increased positions $KRYS $NU $HROW $ETON $4419.T ❌ Exited positions $OPTIMA.AT $TMDX $TBCG.L $4058.T $ASPI 🔻 Trimmed"  [@stock_logging](/creator/x/stock_logging) on [X](/post/tweet/1940065539218460958) 2025-07-01 15:10:43 UTC XXX followers, 24K engagements "$SEZL I always had Sezzle in my shitco / bad business model bucket but this write-up completely changed my view. Brilliantly written and I can highly recommend giving it a read On my WL now"  [@stock_logging](/creator/x/stock_logging) on [X](/post/tweet/1946202920661246434) 2025-07-18 13:38:29 UTC XXX followers, 1783 engagements "@topsecretstocks Interesting pitch Does Pagaya $PGY like Upstart $UPST also hold loans on its own balance sheet or do they carry no credit risk at all"  [@stock_logging](/creator/x/stock_logging) on [X](/post/tweet/1947726871795536232) 2025-07-22 18:34:07 UTC XXX followers, XXX engagements "$6562.T Geniee Inc. Quick pitch: Japanese adtech co. with USD 120m mcap Guidance: XX% revenue and 3540% EBIT growth p.a. through 2030 Forward P/E 2025: XXX 1/3 of revenue comes from a hypergrowth SaaS solution which IMO alone justifies the current mcap Short🧵:"  [@stock_logging](/creator/x/stock_logging) on [X](/post/tweet/1945458310469083362) 2025-07-16 12:19:40 UTC XXX followers, 7975 engagements "@RealYuvaraj Yes I assumed $100m in TPN sales by 2029. Im aware that 2027 is the planned launch year so sales by 2029 could of course be lower maybe closer to $50m. But even in that case the stock would still be undervalued"  [@stock_logging](/creator/x/stock_logging) on [X](/post/tweet/1946801194317320270) 2025-07-20 05:15:49 UTC XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@stock_logging Stock.Logging
Stock.Logging posts on X about $camx, $camxst, $krys, eps the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX +303%
Mentions: XX #
- X Week XX -XX%
- X Month XX +231%
Followers: XXX #
- X Week XXX +7.70%
- X Month XXX +358%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence currencies XXX% countries XXXX% travel destinations XXXX% stocks XXXX% cryptocurrencies XXXX% finance XXXX%
Social topic influence $camx 8.7%, $camxst 8.7%, $krys 8.7%, eps 4.35%, sek 4.35%, india 4.35%, japan 4.35%, currency 4.35%, stockholm 4.35%, aesthetics XXXX%
Top accounts mentioned or mentioned by @marcalcarbo @oddhootcapital @realyuvaraj @themapreducer @exclamotite69 @sycapital @topsecretstocks @szewinvest @joinyellowbrick @mufasa_capital @sy_capital
Top assets mentioned Krystal Biotech, Inc. Common Stock (KRYS) NuCypher (NU) MercadoLibre Inc (MELI) Interlay (INTR) AST SpaceMobile, Inc. Class A Common Stock (ASTS) Sezzle Inc. Common Stock (SEZL) Pagaya Technologies Ltd. Class A Ordinary Shares (PGY) Upstart Holdings, Inc. Common stock (UPST) Hundred Million (100M)
Top Social Posts #
Top posts by engagements in the last XX hours
"$CAMX.ST $CAMX Strong quarterly results from Camurus (part of my biotech basket): ➡ Revenue: SEK 675.5m +51.8% YoY (vs. SEK 653m est.) ➡ Operating profit: SEK 292.05m (43.2% margin) +253.5% YoY ➡ EPS: SEK XXXX +226.4% YoY (vs. SEK XXXX est.) Unchallenged market leader in opioid addiction treatment strong pipeline resubmission for CAM2029 (acromegaly treatment) in the U.S. expected in Q3/25 a recently announced long-term collaboration with Eli Lilly ($LLY) on its proprietary FluidCrystal technology incredible operating leverage lots to like here. In my view one of the best high-growth stocks"
@stock_logging on X 2025-07-17 09:00:25 UTC XXX followers, 1210 engagements
"@MarcalCarbo Absolutely Great thing about X is that so many people share their high-quality research for free really helps clear up misconceptions like this" @stock_logging on X 2025-07-18 13:42:11 UTC XXX followers, XX engagements
"The company operates X segments: Ad Platform: Programmatic advertising platform in Japan with an SSP (publishers / websites monetize ad inventory) a DSP (advertisers/agencies buy ad slots) plus add-on services like publisher support. Cash cow growing 1015% p.a. Overseas Business: Programmatic advertising outside Japan (SEA India U.S.) acquired in 2023 now consolidated under Ad Platform. Digital PR: Acquired in 2024 connects influencers and content creators with brands for marketing campaigns. Marketing SaaS the crown jewel: XX% revenue CAGR since 2021 rising ARPU XXX% churn/quarter. Already" @stock_logging on X 2025-07-16 12:35:26 UTC XXX followers, XXX engagements
"@sy_capital Yes indeed was down almost XX% this morning in Stockholm (I'm on vacation today so lots of time to check stock tickers 😂). Price has recovered meanwhile. Agreed really good numbers. And that despite a currency headwind of XX % 🤯" @stock_logging on X 2025-07-17 10:11:22 UTC XXX followers, XX engagements
"$KRYS Strong study results for Krystal Biotech and its subsidiary Jeune Aesthetics In a randomized double-blind and placebo-controlled Phase X study pipeline candidate KB301 showed significant improvements in severe wrinkles in the dcollet area over XX months as assessed by both investigators (left column) and patients themselves (right column). Important: There is currently no FDA-approved injectable treatment for the dcollet area. Investing in $KRYS therefore not only gives exposure to the market leader in the treatment of dystrophic epidermolysis bullosa (DEB) a rare skin disease but also" @stock_logging on X 2025-07-24 14:11:33 UTC XXX followers, XXX engagements
"$CRMD Ive already increased my Cormedix position by XX% this month and Im considering adding more as the valuation keeps getting cheaper. Below is a simple projection I put together. Feedback appreciated Business model in one sentence (for those unfamiliar with the stock): CorMedix sells DefenCath a catheter lock solution that prevents infections in dialysis patients. Additional indications include TPN (Total Parenteral Nutrition) and oncology. Dialysis: TAM: 37m vials (inpatient) + 3.8m vials (outpatient) = 40.8m vials total (source: company presentation). Price per vial: currently $XXX but" @stock_logging on X 2025-07-19 13:24:31 UTC XXX followers, 4855 engagements
"Portfolio Update June 2025 📊 Performance YTD (measured as TTWROR in EUR): XXXXX % (converted to USD it would be about XX% higher) ➡ Holdings: $INT.ST $INT $SLYG.DE $SLYG $NXSN.TA $NXSN $NU $MELI $7378.T $INTR $ALSTI $ALSTI.PA $247A.T $KURN.SW $KURN $ASTS $5621.T $SOFW.TA $SOFW $4374.T $5134.T $HROW $CAMX.ST $CAMX $4377.T $KRYS $4493.T $277A.T $215A.T $CRMD $4475.T $9911.HK $ALLIX $ALLIX.PA $4419.T $ETON ➕ New positions $CAMX.ST $KURN.SW $215A.T $CRMD $WALLIX.PA $9911.HK 🔼 Increased positions $KRYS $NU $HROW $ETON $4419.T ❌ Exited positions $OPTIMA.AT $TMDX $TBCG.L $4058.T $ASPI 🔻 Trimmed" @stock_logging on X 2025-07-01 15:10:43 UTC XXX followers, 24K engagements
"$SEZL I always had Sezzle in my shitco / bad business model bucket but this write-up completely changed my view. Brilliantly written and I can highly recommend giving it a read On my WL now" @stock_logging on X 2025-07-18 13:38:29 UTC XXX followers, 1783 engagements
"@topsecretstocks Interesting pitch Does Pagaya $PGY like Upstart $UPST also hold loans on its own balance sheet or do they carry no credit risk at all" @stock_logging on X 2025-07-22 18:34:07 UTC XXX followers, XXX engagements
"$6562.T Geniee Inc. Quick pitch: Japanese adtech co. with USD 120m mcap Guidance: XX% revenue and 3540% EBIT growth p.a. through 2030 Forward P/E 2025: XXX 1/3 of revenue comes from a hypergrowth SaaS solution which IMO alone justifies the current mcap Short🧵:" @stock_logging on X 2025-07-16 12:19:40 UTC XXX followers, 7975 engagements
"@RealYuvaraj Yes I assumed $100m in TPN sales by 2029. Im aware that 2027 is the planned launch year so sales by 2029 could of course be lower maybe closer to $50m. But even in that case the stock would still be undervalued" @stock_logging on X 2025-07-20 05:15:49 UTC XXX followers, XXX engagements